Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 19 Neoplasms 11 Polycystic Ovary Syndrome 9 Neoplasm Metastasis 4 Multiple Myeloma 4 Melanoma 4 Vomiting 3 Prostatic Neoplasms 3 Leukemia, Myeloid, Acute 3 Leiomyoma 3 Head and Neck Neoplasms 3 Endometrial Neoplasms 3 Triple Negative Breast Neoplasms 2 Solid Tumors 2 Skin Neoplasms 2 Sarcoma 2 Recurrence 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Peripheral Nervous System Diseases 2 Ovarian Neoplasms 2 Obesity 2 Nausea 2 Myofibroma 2 Lung Neoplasms 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Leukemia, B-Cell 2 Leukemia 2 Insulin Resistance 2 Inflammation 2 Infertility, Female 2

Interventions

Melphalan 3 Blood Specimen Collection 3 Magnetic Resonance Spectroscopy 2 thymoglobulin 1 sargramostim 1 romidepsin 1 montanide ISA 51 1 keyhole-limpet hemocyanin 1 ixazomib 1 detox adjuvant 1 Waiting Lists 1 Ursodeoxycholic Acid 1 Transplantation 1 Thalidomide 1 Tablets 1 Surveys and Questionnaires 1 Streptozocin 1 Specimen Handling 1 Restraint, Physical 1 Radiosurgery 1 Radiation 1 Mercaptopurine 1 Leucovorin 1 Ketoconazole 1 Interleukin-2 1 Fulvestrant 1 Floxuridine 1 FANG vaccine 1 Docetaxel 1 Diagnostic Tests, Routine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Genetic Diseases, Inborn × Tablets × Clear all

NCT05392608 2026-05-22

SEQUEL-Breast

Borstkanker Onderzoek Groep

Phase 2 Active not recruiting

Breast Neoplasms, Genetic Diseases, Inborn

Data powered by HemOnc (CC BY 4.0) Colophon ⚡